Methods of determining glucose concentration in whole blood samples

• US 20040079652A1
• Filed: 08/22/2003
• Published: 04/29/2004
• Est. Priority Date: 08/27/2002
• Status: Abandoned Application

• Current Assignee: Bayer Healthcare LLC (Bayer AG)
• Original Assignee: Bayer Healthcare LLC (Bayer AG)
• Inventors: Vreeke, Mark S., Melle, Bryan S., Genshaw, Marvin A.
• Application Number:
  US10/645,785
• Publication Number:
  US 20040079652A1
• Time in Patent Office: Days
• US Class Current: 205/777.5
• CPC Class Codes: G01N 27/3274 Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration coding of calibration information G01N33/48771
• CPC Class Codes: G01N 33/66 involving blood sugars, e.g. galactose

Abstract

The glucose concentration in a whole blood sample may be determined by providing an electrochemical sensor adapted to measure glucose and hematocrit concentrations. The hematocrit concentration of the whole blood sample is measured using the electrochemical sensor via electrochemical impedance spectroscopy. The initial glucose concentration of the whole blood sample is measured using the electrochemical sensor. The unbiased glucose concentration in the whole blood sample is calculated using the initial glucose concentration measurement and the hematocrit concentration.

Claims

1. A method of determining glucose concentration in a whole blood sample comprising:

providing an electrochemical sensor adapted to measure glucose and hematocrit concentrations;

measuring the hematocrit concentration of the whole blood sample using the electrochemical sensor via electrochemical impedance spectroscopy;

measuring the initial glucose concentration of the whole blood sample using the electrochemical sensor; and

calculating the unbiased glucose concentration in the whole blood sample using the initial glucose concentration measurement and the hematocrit concentration.

2. The method of claim 1, wherein the glucose concentration of the whole blood sample is determined using an amperometric monitoring system.

3. The method of claim 1, wherein the electrochemical sensor includes an insulating base plate, an electrode system on the base plate and a cover adapted to mate with the base plate to form a space in which the electrode layer is available to contact the whole blood sample.

4. The method of claim 3 further including a reaction layer comprising an enzyme that reacts with the glucose in the whole blood sample.

5. The method of claim 4, wherein the enzyme in the reaction layer is combined with a hydrophilic polymer.

6. The method of claim 1, wherein the method of determining glucose concentration in a whole blood sample occurs in disposable self-testing systems.

7. The method of claim 1, wherein the method of determining glucose concentration in a whole blood sample occurs in a clinical analyzer.

8. The method of claim 1, wherein the measuring of the hematocrit concentration in the whole blood sample is performed before measuring the initial glucose concentration.

9. The method of claim 1, wherein the measuring of the hematocrit concentration of the whole blood sample is performed using a single frequency measurement.

10. The method of claim 1, wherein the measuring of the hematocrit concentration of the whole blood sample is performed using a plurality of frequency measurements.

11. The method of claim 1, wherein the measuring of the hematocrit concentration is performed using a phase shift of an impedance measurement.

12. The method of claim 11, wherein the measuring of the hematocrit concentration is performed with at least one frequency between about 800 and about 900 Hz.

13. The method of claim 1, wherein the measuring of the hematocrit concentration is performed using magnitude components of an impedance measurement.

14. The method of claim 13, wherein the measuring of the hematocrit is performed with at least one frequency between about 300 and about 10,000 Hz.

15. The method of claim 1 further including applying AC waveforms from about 1 to about 10,000 Hz to the electrochemical sensor.

16. The method of claim 1 further including applying AC waveforms from about 1 to about 100 mV to the electrochemical sensor.

17. The method of claim 1 further applying AC waveforms that are subsequently deconvoluted using a Fourier transform.

18. A method of determining glucose concentration in a whole blood sample comprising:

providing an electrochemical sensor adapted to measure glucose and hematocrit concentrations;

measuring the hematocrit concentration of the whole blood sample using the electrochemical sensor via electrochemical impedance spectroscopy using an amperometric monitoring system;

measuring the initial glucose concentration of the whole blood sample using the electrochemical sensor; and

calculating the unbiased glucose concentration in the whole blood sample using the initial glucose concentration measurement and the hematocrit concentration.

19. The method of claim 18, wherein the method of determining glucose concentration in a whole blood sample occurs in disposable self-testing systems.

20. The method of claim 19, wherein the measuring of the hematocrit concentration of the whole blood sample is performed using a single frequency measurement.

21. The method of claim 19, wherein the measuring of the hematocrit concentration of the whole blood sample is performed using a plurality of frequency measurements.

22. The method of claim 19, wherein the measuring of the hematocrit concentration is performed using a phase shift of an impedance measurement.

23. The method of claim 22, wherein the measuring of the hematocrit concentration is performed with at least one frequency between about 800 and about 900 Hz.

24. The method of claim 19, wherein the measuring of the hematocrit concentration is performed using magnitude components of an impedance measurement.

25. The method of claim 24, wherein the measuring of the hematocrit is performed with at least one frequency between about 300 and about 10,000 Hz.

26. The method of claim 19 further including applying AC waveforms from about 1 to about 10,000 Hz to the electrochemical sensor.

27. The method of claim 19 further including applying AC waveforms from about 1 to about 100 mV to the electrochemical sensor.

28. The method of claim 19 further applying AC waveforms that are subsequently deconvoluted using a Fourier transform.